# PHESGO
> **BLA761170** · Biologics License Application · Sponsor: GENENTECH INC · Approved 2020-06-29
## Drug
- **FDA Application Number:** BLA761170
- **Application type:** Biologics License Application
- **Brand name:** PHESGO
- **Generic name:** PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF
- **Active ingredients:** PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** GENENTECH INC
- **Manufacturer:** Genentech, Inc.
- **First approval:** 2020-06-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761170)
---
*AI Analytics · CC0 1.0*